[HONG KONG, August 16,2021] Recently, Great Bay Bio Holdings Limited (hereinafter referred to as“GBB”) was listed in SCMP’s AsiaSustainability Conference, expecting to rank as one of the TOP 10 mostpotential start-ups by the South China Morning Post (SCMP

[July 5, 2021 - Hong Kong] Great Bay Bio Holdings Limited (hereinafter referred to as “GBB”) announces that the company’s self-developed intelligent cell line stability prediction platform AlfaStaX, is officially launched. Given the easy accessibility an

[HONG KONG, May 8, 2021] Chairman of Great Bay Bio Limited, Mr. Kingsley Leung, was invited to participate in the "Youth Novation Start-up Cmpetition" hosted by Hong Kong Youth Development Alliance. Hong Kong Youth Development Alliance (YDAHK) is committ

[HONG KONG, April 29, 2021] Hong Kong Science and Technology Parks Corporation (HKSTP) and Federation of Hong Kong Industries (FHKI) today launched the joint R&D Hub programme to give visionary leaders and businesses from Hong Kong’s manufacturing industr

[Hong Kong, March 31, 2021] Great Bay Bio Holdings Limited (hereinafter referred to as “GBB”) is pleased to announce that the company’s self-developed AI-enabled cell culture media development platform, AlfaMedX®, is officially launched. AlfaMedX is crea

[Hong Kong, February 23, 2021] Great Bay Bio Holdings Limited (hereinafter referred to as "GBB") today announced it has completed a USD$3.8M Convertible Note Financing. Alibaba Hong Kong Entrepreneurs Fund (hereinafter referred to as "AEF") led the invest

[Hong Kong, January 22, 2021]Recently, theGreat Bay Bio Family celebrated the past year’s achievement in a special way.

[香港，2020年12月24日] 近日，大湾生物再次获评高新技术企业。 高新技术企业属于国家级荣誉，是指在《国家重点支持的高新技术领域》内持续进行研究开发与技术成果转化，形成企业核心自主知识产权，并以此为基